Safety of PCI-32765 in Chronic Lymphocytic Leukemia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
The purpose of this study is to establish the safety and efficacy of orally administered PCI-32765 in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Epistemonikos ID: b47280376eb7bf283774969a3aed43f09c62a94c
First added on: Jan 21, 2022